Diagnosis of interstitial lung diseases

Mayo Clinic Proceedings

Volumn 82, Issue 8, 2007, Pages 976-986

  Ryu, Jay H ^a   Daniels, Craig E ^a   Hartman, Thomas E ^a   Yi, Eunhee S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HISTOPATHOLOGY; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG FIBROSIS; REVIEW; SARCOIDOSIS; SEROLOGY;

EID: 34547640311     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.8.976     Document Type: Review

References (97)

1. Colby TV, Swensen SJ. Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation with HRCT [published correction appears in J Thorac Imaging. Spring 1996;11:163]. J Thorac Imaging. Winter 1996;11:1-26.
2. Reynolds HY. Diagnostic and management strategies for diffuse interstitial lung disease. Chest. 1998;113:192-202.
3. British Thoracic Society Standards of Care Committee. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax. 1999;54(suppl 1):S1-S30.
4. Ryu JH, Olson EJ, Midthun DE, Swensen SJ. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc. 2002;77:1221-1227.
5. Barbato A, Panizzolo C, Cracco A, de Blic J, Dinwiddie R, Zach M. Interstitial lung disease in children: a multicentre survey on diagnostic approach. Eur Respir J. 2000;16:509-513.
6. Leslie KO. Pathology of interstitial lung disease. Clin Chest Med. 2004;25:657-703.
7. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias [published correction appears in Am J Respir Crit Care Med. 2002;166:426]. Am J Respir Crit Care Med. 2002;165:277-304.
8. American Thoracic Society, European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med. 2000;161(2, pt 1):646-664.
9. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199-203.
10. Ryu JH, Colby TV, Hartman TE. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc. 1998;73:1085-1101.
11. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517-525.
12. Swigris JJ, Kuschner WG, Kelsey JL, Gould MK. Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest. 2005;127:275-283.
13. Lynch D, David Goodwin J, Safrin S, et al, Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005 Aug 15;172:488-493. Epub 2005 May 13.
14. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:193-196.
15. Elliot TL, Lynch DA, Newell JD Jr, et al. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr. 2005;29:339-345.
16. American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736-755.
17. Zinck SE, Schwartz E, Berry GJ, Leung AN. CT of noninfectious granulomatous lung disease. Radiol Clin N Am. 2001;39:1189-1209.
18. Ryu JH, Bongartz T, Matteson EL. Interstitial lung disease in connective tissue diseases: what are the important questions? [editorial]. Arthritis Rheum. 2005;53:488-490.
19. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182-1185.
20. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44:585-596.
21. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127:2019-2027.
22. Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue disease. Chest. 2006;130:553-558.
23. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren's syndrome. Chest. 2006;130:1489-1495.
24. Glazer CS, Newman LS. Occupational interstitial lung disease. Clin Chest Med. 2004;25:467-478.
25. Kim KI, Kim CW, Lee MK, et al. Imaging of occupational lung disease. Radiographics. 2001;21:1371-1391.
26. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001;108:661-670.
27. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004;25:531-547.
28. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med. 2006 Apr;100:610-615. Epub 2005 Sep 27.
29. Glazer CS, Rose CS, Lynch DA. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging. 2002;17:261-272.
30. Hartman TE. The HRCT features of extrinsic allergic alveolitis. Semin Respir Crit Care Med. 2003;24:419-426.
31. Myers JL, Limper AH, Swensen SJ. Drug-induced lung disease: a pragmatic classification incorporating HRCT appearances. Semin Respir Crit Care Med. 2003;24:445-454.
32. Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004;25:479-519.
33. Erasmus JJ, McAdams HP, Rossi SE. High-resolution CT of druginduced lung disease. Radiol Clin North Am. 2002;40:61-72.
34. Cleverley JR, Screaton NJ, Hiorns MP, Flint JD, Muller NL. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 2002;57:292-299.
35. Mendez JL, Nadrous HF, Hartman TE, Ryu JH. Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc. 2005;80:1298-1302.
36. Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J. 2001;17:122-132.
37. Vassallo R, Ryu JH. Pulmonary Langerhans' cell histiocytosis. Clin Chest Med. 2004;25:561-571.
38. Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA. 2004;292:2997-3005.
39. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine (Baltimore). 1996;75:334-342.
40. Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med. 1997;155:296-302.
41. Philit F, Etienne-Mastroïanni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002;166:1235-1239.
42. Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005;127:178-184.
43. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969-1978.
44. Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J. 2006;27:1272-1285.
45. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med. 1978;298:934-939.
46. Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980;30:411-426.
47. McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology. 1983;149:353-363.
48. Müller NL. Advances in imaging. Eur Respir J. 2001;18:867-871.
49. Hansell DM. High-resolution CT of diffuse lung disease: value and limitations. Radiol Clin North Am. 2001;39:1091-1113.
50. Collins J. CT signs and patterns of lung disease. Radiol Clin North Am. 2001;39:1115-1135.
51. Griffin CB, Primack SL. High-resolution CT: normal anatomy, techniques, and pitfalls. Radiol Clin North Am. 2001;39:1073-1090.
52. Remy-Jardin M, Dumont P, Remy J. High-resolution computed tomography techniques in diffuse parenchymal lung disease and their application to clinical practice. Semin Respir Crit Care Med. 2003;24:333-346.
53. MacDonald S, Muller NL. Insights from HRCT: how they affect the management of diffuse parenchymal lung disease. Semin Respir Crit Care Med. 2003;24:357-364.
54. Wells AU. High-resolution computed tomography in the diagnosis of diffuse lung disease: a clinical perspective. Semin Respir Crit Care Med. 2003;24:347-356.
55. Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236:10-21.
56. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005 Aug;172:268-279. Epub 2005 May 5.
57. Ryu JH, Swensen SJ. Cystic and cavitary lung diseases: focal and diffuse. Mayo Clin Proc. 2003;78:744-752.
58. Ryu JH, Moss J, Beck GJ, et al, NHLBI LAM Registry Group. The NHLBI Lymphangioleiomyomatosis Registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006 Jan 1;173:105-111. Epub 2005 Oct 6.
59. Garcia CK, Raghu G. Inherited interstitial lung disease [published correction appears in Clin Chest Med. 2004;25:xi]. Clin Chest Med. 2004;25:421-433.
60. Almoosa KF, Ryu JH, Mendez J, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest. 2006;129:1274-1281.
61. Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest. 2004;125:1028-1032.
62. Schwarz MI, Albert RK. "Imitators" of the ARDS: implications for diagnosis and treatment. Chest. 2004;125:1530-1535.
63. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest. 2005;128:3310-3315.
64. Glassberg MK. Lymphangioleiomyomatosis. Clin Chest Med. 2004;25:573-582.
65. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27:1056-1065.
66. Koyama M, Johkoh T, Honda O, et al. Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol. 2003;180:827-835.
67. Franquet T, Hansell DM, Senbanjo T, Remy-Jardin M, Muller NL. Lung cysts in subacute hypersensitivity pneumonitis. J Comput Assist Tomogr. 2003;27:475-478.
68. Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1999;212:567-572.
69. Ioachimescu OC, Sieber S, Walker MJ, Rella V, Kotch A. A 35-year-old woman with asthma and polycystic lung disease. Chest. 2002;121:256-260.
70. Colombat M, Stern M, Groussard O, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006 Apr 1;173:777-780. Epub 2006 Jan 6.
71. Butnor KJ, Guinee DG Jr. Pleuropulmonary pathology of Birt-Hogg-Dubé syndrome. Am J Surg Pathol. 2006;30:395-399.
72. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168:1277-1292.
73. Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest. 2003;123:623-627.
74. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med. 2006 Apr 1;173:744-750. Epub 2006 Jan 13.
75. Ryu JH, Scanlon PD. Obstructive lung diseases: COPD, asthma, and many imitators. Mayo Clin Proc. 2001;76:1144-1153.
76. Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;144(3, pt 1):504-506.
77. Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52:998-1002.
78. Strange C, Highland KB. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med. 2005;11:452-455.
79. Chaowalit, N, Pellikka, PA, Decker, PA, et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc. 2004;79:1269-1275.
80. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:2393-2399.
81. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006 Jan;61:68-74. Epub 2005 Oct 14.
82. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000;161:216-223.
83. Raghu G. The role of gastroesophageal reflux in idiopathic pulmonary fibrosis. Am J Med. 2003;115(suppl 3A):60S-64S.
84. Barnes TW, Vassallo R, Hartman TE, Tazelaar HD, Ryu JH. Diffuse bronchiolar disease due to chronic occult aspiration. Mayo Clin Proc. 2006;81:172-176.
85. Casey MB, Tazelaar HD, Myers JL, et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol. 2003;27:213-219.
86. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25:637-649.
87. Presneill JJ, Nakata K, Inoue Y, Seymour JF. Pulmonary alveolar proteinosis. Clin Chest Med. 2004;25:593-613.
88. Verbeken EK. Classifying interstitial lung disease in a fractal lung: a morphologist's view "anno Domini 2000." Eur Respir J Suppl. 2001;32:107s-113s.
89. Halkos ME, Gal AA, Kerendi F, Miller DL, Miller JI Jr. Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease. Ann Thorac Surg. 2005;79:2172-2179.
90. Rizzato G. The role of thoracic surgery in diagnosing interstitial lung disease. Curr Opin Pulm Med. 1999;5:284-286.
91. Boutin C, Astoul P. Diagnostic thoracoscopy. Clin Chest Med. 1998;19:295-309.
92. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001;164:1722-1727.
93. Utz JP, Ryu JH, Douglas WW, et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J. 2001;17:175-179.
94. Caples SM, Utz JP, Allen MS, Ryu JH. Thoracic surgical procedures in patients with rheumatoid arthritis. J Rheumatol. 2004;31:2136-2141.
95. Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR, Shorr AF. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005;127:1600-1605.
96. Riley DJ. Risk of surgical lung biopsy in idiopathic interstitial pneumonias [editorial]. Chest. 2005;127:1485-1486.
97. Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004;59:500-505.